Main Article Content

Authors

Introduction: Sarcoidosis is a systemic granulomatosis of unknown etiology that can manifest acutely as Löfgren’s syndrome in 20-50% of the individuals, which despite having a benign course, requires careful monitoring and follow-up of patients. This syndrome characterized by erythema nodosum, bilateral hilar lymphadenopathy and polyartralgia or polyarthritis, does not require histological evidence for the diagnosis and is more prevalent in caucasian women until the age of 30 years. It has good prognosis and may have spontaneous resolution of complaints usually occur in the first year after the onset. Case Presentation: The authors present the case of a 20-year-old female who went to the emergency department with complaints of nodular, reddish and painful lesions in the lower limbs, accompanied by general malaise and bilateral knee pain associated with functional impotence. Conclusion: Radiographic changes and elevation of the serum angiotensin converting enzyme were observed, with the patient responding well to a short course of corticosteroids and analgesia with nonsteroidal anti-inflammatory drugs.

Joana Cascais Costa, Hospital Geral, Centro Hospitalar e Universitário de Coimbra.

Hospital Geral, Centro Hospitalar e Universitário de Coimbra.

Catarina Lucas, Hospital Geral, Centro Hospitalar e Universitário de Coimbra.

Hospital Geral, Centro Hospitalar e Universitário de Coimbra.

Joana Paixão, Hospital Geral, Centro Hospitalar e Universitário de Coimbra.

Hospital Geral, Centro Hospitalar e Universitário de Coimbra.

Adriano Rodrigues, Hospital Geral, Centro Hospitalar e Universitário de Coimbra.

Hospital Geral, Centro Hospitalar e Universitário de Coimbra.
Cascais Costa, J., Lucas, C., Paixão, J., & Rodrigues, A. (2019). Löfgren Syndrome: Sarcoidosis’s Best Scenario. Revista Ciencias De La Salud, 17(1), 149–155. https://doi.org/10.12804/revistas.urosario.edu.co/revsalud/a.7624

Löfgren S, Lundback H. The bilateral hilar lymphoma syndrome; a study of the relation to tuberculosis and sarcoidosis in 212 cases. Acta Med Scand 1952;142:265-73.

Siltzbach LE, James DG, Neville E, Turiaf J, Battesti JP, Sharna OP, et al. Course and prognosis of sarcoidosis around the world. Am J Med 1974;57:847- 52. Doi: 10.1016/0002- 9343(74)90160-0

Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007; 357:2153. Doi: 10.1056/NEJMra071714

Zisman DA, Shorr AF, Lynch JP. 3rd. Sarcoidosis involving the musculoskeletal system. Semin Respir Crit Care Med 2002;23:555-70. Doi: 10.1055/s-2002-36520

Dempsey OJ, Paterson EW, Kerr KM, Denison AR. Sarcoidosis BMJ. 2009;339 :b3206. Doi: https://doi.org/10.1136/bmj.b3206

Nessrine A, Zahra AF, Taoufik H. Musculoskeletal involvement in sarcoidosis. J Bras Pneumol. 2014;40:175-82. Doi: 10.1590/S1806-37132014000200012

Kobak S. Sarcoidosis: a rheumatologist’s perspective. Ther Adv Musculoskelet Dis. 2015;7(5):196-205. Doi: 10.1177/1759720X15591310

Sweiss NJ, Patterson K, Sawaqed R, Jabbar U, Korsten P, Hogarth K, et al. Rheumatologic manifestations of sarcoidosis. Semin Respir Crit Care Med. 2010;31(4):463-73. Doi: 10.1055/s-0030-1262214

Mana J, Gormez-Vaquero C, Montero A, Salazar A, Marcoval J, Valverde J. Löfgren’s syndrome revisited: a study of 186 patients. Am J Med 1999;107:240-5. PMID: 10492317

Moller DR, Rybicki BA, Hamzeh NY, Montgomery CG, Chen ES, Drake W. et al. Genetic, Immunologic, and Environmental Basis of Sarcoidosis. Ann Am Thorac Soc. 2017;14(6):S429-36. Doi: 10.1513/AnnalsATS.201707-565OT

Ungprasert P, Crowson CS, Matteson EL. Influence of Gender on Epidemiology and Clinical Manifestations of Sarcoidosis: A Population-Based Retrospective Cohort Study 1976-2013. 2017;195:87. Doi: 10.1007/s00408-016-9952-6

Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H Jr, Bresnitz EA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001;164:1885. Doi: 10.1164/ajrccm.164.10.2104046

Grunewald J, Eklund A. Sex-specific manifestations of Löfgren’s syndrome. Am J Respir Crit Care Med 2007;175:40-4. Doi: 10.1164/rccm.200608-1197OC

Miedema JR, Kaiser Y, Broos CE, Wijsenbeek MS, Grunewald J, Kool M. Th17-lineage cells in pulmonary sarcoidosis and Löfgren’s syndrome: Friend or foe? J. Autoimmun. 2018;87:82-96. Doi: 10.1016/j.jaut.2017.12.012

Chen ES, Moller DR. Sarcoidosis-scientific progress and clinical challenges. Nature reviews. Rheumatology 2011;7(8):457-67. Doi: 10.1038/nrrheum.2011.93

Ungprasert P, Carmona EM, Crowson CS, Matteson EL. Diagnostic Utility of Angiotensin- Converting Enzyme in Sarcoidosis: A Population-Based Study. Lung 2016; 194:91. Doi: 10.1007/s00408-015-9826-3

Ma Y, Gal A, Koss MN. The pathology of pulmonary sarcoidosis: update. Semin Diagn Pathol 2007;24:150. PMID: 17882899.

James WE, Baughman R. Treatment of sarcoidosis: grading the evidence. Expert Rev Clin Pharmacol. 2018;11(7):677-87. Doi: 10.1080/17512433.2018.1486706

Sauer WH, Stern BJ, Baughman RP, Culver DA, Royal W. High-Risk Sarcoidosis. Current Concepts and Research Imperatives. Ann Am Thorac Soc. 2017;14(6):S437-44. Doi: 10.1513/AnnalsATS.201707-566OT

Downloads

Download data is not yet available.

Most read articles by the same author(s)

Similar Articles

1 2 3 4 > >> 

You may also start an advanced similarity search for this article.